List of Tables
Table 1. Cold Sore Antiviral Drug Market Trends
Table 2. Cold Sore Antiviral Drug Market Drivers & Opportunity
Table 3. Cold Sore Antiviral Drug Market Challenges
Table 4. Cold Sore Antiviral Drug Market Restraints
Table 5. Global Cold Sore Antiviral Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cold Sore Antiviral Drug Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Cold Sore Antiviral Drug Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Cold Sore Antiviral Drug Product Type
Table 9. Key Companies Time to Begin Mass Production of Cold Sore Antiviral Drug
Table 10. Global Cold Sore Antiviral Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold Sore Antiviral Drug as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Cold Sore Antiviral Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Cold Sore Antiviral Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Cold Sore Antiviral Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Cold Sore Antiviral Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Cold Sore Antiviral Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Cold Sore Antiviral Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Cold Sore Antiviral Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Cold Sore Antiviral Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Cold Sore Antiviral Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Cold Sore Antiviral Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Cold Sore Antiviral Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Cold Sore Antiviral Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Cold Sore Antiviral Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Cold Sore Antiviral Drug Sales Value by Region (2019-2024) & (%)
Table 27. Global Cold Sore Antiviral Drug Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Cold Sore Antiviral Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Cold Sore Antiviral Drug Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Cold Sore Antiviral Drug Sales Value, (2025-2030) & (US$ Million)
Table 31. GlaxoSmithKline Basic Information List
Table 32. GlaxoSmithKline Description and Business Overview
Table 33. GlaxoSmithKline Cold Sore Antiviral Drug Products, Services and Solutions
Table 34. Revenue (US$ Million) in Cold Sore Antiviral Drug Business of GlaxoSmithKline (2019-2024)
Table 35. GlaxoSmithKline Recent Developments
Table 36. Ortho Dermatologics Basic Information List
Table 37. Ortho Dermatologics Description and Business Overview
Table 38. Ortho Dermatologics Cold Sore Antiviral Drug Products, Services and Solutions
Table 39. Revenue (US$ Million) in Cold Sore Antiviral Drug Business of Ortho Dermatologics (2019-2024)
Table 40. Ortho Dermatologics Recent Developments
Table 41. Foundation Consumer Healthcare Basic Information List
Table 42. Foundation Consumer Healthcare Description and Business Overview
Table 43. Foundation Consumer Healthcare Cold Sore Antiviral Drug Products, Services and Solutions
Table 44. Revenue (US$ Million) in Cold Sore Antiviral Drug Business of Foundation Consumer Healthcare (2019-2024)
Table 45. Foundation Consumer Healthcare Recent Developments
Table 46. Novartis Basic Information List
Table 47. Novartis Description and Business Overview
Table 48. Novartis Cold Sore Antiviral Drug Products, Services and Solutions
Table 49. Revenue (US$ Million) in Cold Sore Antiviral Drug Business of Novartis (2019-2024)
Table 50. Novartis Recent Developments
Table 51. Teva Pharmaceuticals Basic Information List
Table 52. Teva Pharmaceuticals Description and Business Overview
Table 53. Teva Pharmaceuticals Cold Sore Antiviral Drug Products, Services and Solutions
Table 54. Revenue (US$ Million) in Cold Sore Antiviral Drug Business of Teva Pharmaceuticals (2019-2024)
Table 55. Teva Pharmaceuticals Recent Developments
Table 56. Amneal Pharmaceuticals LLC Basic Information List
Table 57. Amneal Pharmaceuticals LLC Description and Business Overview
Table 58. Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Products, Services and Solutions
Table 59. Revenue (US$ Million) in Cold Sore Antiviral Drug Business of Amneal Pharmaceuticals LLC (2019-2024)
Table 60. Amneal Pharmaceuticals LLC Recent Developments
Table 61. AiCuris Basic Information List
Table 62. AiCuris Description and Business Overview
Table 63. AiCuris Cold Sore Antiviral Drug Products, Services and Solutions
Table 64. Revenue (US$ Million) in Cold Sore Antiviral Drug Business of AiCuris (2019-2024)
Table 65. AiCuris Recent Developments
Table 66. Apotex Basic Information List
Table 67. Apotex Description and Business Overview
Table 68. Apotex Cold Sore Antiviral Drug Products, Services and Solutions
Table 69. Revenue (US$ Million) in Cold Sore Antiviral Drug Business of Apotex (2019-2024)
Table 70. Apotex Recent Developments
Table 71. Aurobindo Pharma USA, Inc. Basic Information List
Table 72. Aurobindo Pharma USA, Inc. Description and Business Overview
Table 73. Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Products, Services and Solutions
Table 74. Revenue (US$ Million) in Cold Sore Antiviral Drug Business of Aurobindo Pharma USA, Inc. (2019-2024)
Table 75. Aurobindo Pharma USA, Inc. Recent Developments
Table 76. Cipla Basic Information List
Table 77. Cipla Description and Business Overview
Table 78. Cipla Cold Sore Antiviral Drug Products, Services and Solutions
Table 79. Revenue (US$ Million) in Cold Sore Antiviral Drug Business of Cipla (2019-2024)
Table 80. Cipla Recent Developments
Table 81. Glenmark Pharmaceuticals, Inc. Basic Information List
Table 82. Glenmark Pharmaceuticals, Inc. Description and Business Overview
Table 83. Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Products, Services and Solutions
Table 84. Revenue (US$ Million) in Cold Sore Antiviral Drug Business of Glenmark Pharmaceuticals, Inc. (2019-2024)
Table 85. Glenmark Pharmaceuticals, Inc. Recent Developments
Table 86. Hikma Pharmaceuticals Basic Information List
Table 87. Hikma Pharmaceuticals Description and Business Overview
Table 88. Hikma Pharmaceuticals Cold Sore Antiviral Drug Products, Services and Solutions
Table 89. Revenue (US$ Million) in Cold Sore Antiviral Drug Business of Hikma Pharmaceuticals (2019-2024)
Table 90. Hikma Pharmaceuticals Recent Developments
Table 91. HRA Pharma Basic Information List
Table 92. HRA Pharma Description and Business Overview
Table 93. HRA Pharma Cold Sore Antiviral Drug Products, Services and Solutions
Table 94. Revenue (US$ Million) in Cold Sore Antiviral Drug Business of HRA Pharma (2019-2024)
Table 95. HRA Pharma Recent Developments
Table 96. Hetero Healthcare Ltd Basic Information List
Table 97. Hetero Healthcare Ltd Description and Business Overview
Table 98. Hetero Healthcare Ltd Cold Sore Antiviral Drug Products, Services and Solutions
Table 99. Revenue (US$ Million) in Cold Sore Antiviral Drug Business of Hetero Healthcare Ltd (2019-2024)
Table 100. Hetero Healthcare Ltd Recent Developments
Table 101. Jubilant Cadista Basic Information List
Table 102. Jubilant Cadista Description and Business Overview
Table 103. Jubilant Cadista Cold Sore Antiviral Drug Products, Services and Solutions
Table 104. Revenue (US$ Million) in Cold Sore Antiviral Drug Business of Jubilant Cadista (2019-2024)
Table 105. Jubilant Cadista Recent Developments
Table 106. Merix Pharmaceutical Corp Basic Information List
Table 107. Merix Pharmaceutical Corp Description and Business Overview
Table 108. Merix Pharmaceutical Corp Cold Sore Antiviral Drug Products, Services and Solutions
Table 109. Revenue (US$ Million) in Cold Sore Antiviral Drug Business of Merix Pharmaceutical Corp (2019-2024)
Table 110. Merix Pharmaceutical Corp Recent Developments
Table 111. Sun Pharmaceutical Industries Ltd. Basic Information List
Table 112. Sun Pharmaceutical Industries Ltd. Description and Business Overview
Table 113. Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Products, Services and Solutions
Table 114. Revenue (US$ Million) in Cold Sore Antiviral Drug Business of Sun Pharmaceutical Industries Ltd. (2019-2024)
Table 115. Sun Pharmaceutical Industries Ltd. Recent Developments
Table 116. Viatris Basic Information List
Table 117. Viatris Description and Business Overview
Table 118. Viatris Cold Sore Antiviral Drug Products, Services and Solutions
Table 119. Revenue (US$ Million) in Cold Sore Antiviral Drug Business of Viatris (2019-2024)
Table 120. Viatris Recent Developments
Table 121. Wockhardt Basic Information List
Table 122. Wockhardt Description and Business Overview
Table 123. Wockhardt Cold Sore Antiviral Drug Products, Services and Solutions
Table 124. Revenue (US$ Million) in Cold Sore Antiviral Drug Business of Wockhardt (2019-2024)
Table 125. Wockhardt Recent Developments
Table 126. Zydus Pharmaceuticals Basic Information List
Table 127. Zydus Pharmaceuticals Description and Business Overview
Table 128. Zydus Pharmaceuticals Cold Sore Antiviral Drug Products, Services and Solutions
Table 129. Revenue (US$ Million) in Cold Sore Antiviral Drug Business of Zydus Pharmaceuticals (2019-2024)
Table 130. Zydus Pharmaceuticals Recent Developments
Table 131. Key Raw Materials Lists
Table 132. Raw Materials Key Suppliers Lists
Table 133. Cold Sore Antiviral Drug Downstream Customers
Table 134. Cold Sore Antiviral Drug Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 138. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Cold Sore Antiviral Drug Product Picture
Figure 2. Global Cold Sore Antiviral Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cold Sore Antiviral Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Cold Sore Antiviral Drug Report Years Considered
Figure 5. Global Cold Sore Antiviral Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Cold Sore Antiviral Drug Revenue in 2023
Figure 7. Cold Sore Antiviral Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Smear Picture
Figure 9. Oral Picture
Figure 10. Others Picture
Figure 11. Global Cold Sore Antiviral Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Cold Sore Antiviral Drug Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Child
Figure 14. Product Picture of Aldult
Figure 15. Global Cold Sore Antiviral Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Cold Sore Antiviral Drug Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Cold Sore Antiviral Drug Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Cold Sore Antiviral Drug Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Cold Sore Antiviral Drug Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Cold Sore Antiviral Drug Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Cold Sore Antiviral Drug Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Cold Sore Antiviral Drug Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Cold Sore Antiviral Drug Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Cold Sore Antiviral Drug Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Cold Sore Antiviral Drug Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Cold Sore Antiviral Drug Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Cold Sore Antiviral Drug Sales Value (%), (2019-2030)
Figure 28. United States Cold Sore Antiviral Drug Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Cold Sore Antiviral Drug Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Cold Sore Antiviral Drug Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Cold Sore Antiviral Drug Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Cold Sore Antiviral Drug Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Cold Sore Antiviral Drug Sales Value by Application (%), 2023 VS 2030
Figure 34. China Cold Sore Antiviral Drug Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Cold Sore Antiviral Drug Sales Value by Type (%), 2023 VS 2030
Figure 36. China Cold Sore Antiviral Drug Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Cold Sore Antiviral Drug Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Cold Sore Antiviral Drug Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Cold Sore Antiviral Drug Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Cold Sore Antiviral Drug Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Cold Sore Antiviral Drug Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Cold Sore Antiviral Drug Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Cold Sore Antiviral Drug Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Cold Sore Antiviral Drug Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Cold Sore Antiviral Drug Sales Value by Application (%), 2023 VS 2030
Figure 46. India Cold Sore Antiviral Drug Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Cold Sore Antiviral Drug Sales Value by Type (%), 2023 VS 2030
Figure 48. India Cold Sore Antiviral Drug Sales Value by Application (%), 2023 VS 2030
Figure 49. Cold Sore Antiviral Drug Industrial Chain
Figure 50. Cold Sore Antiviral Drug Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
